Key Metrics
Print   |  A  |  A
Feasibility Processing
  • CTA will evaluate protocol concepts or preclinical data within 5 working days of receiving presentations from the sponsor.
  • Assessments/ Expression of interests to participate in multisite/global studies can be evaluated in 10 working days from receipt by the Member Services Manager.
Human Research & Ethics Approval

Post receipt of comprehensive protocols and investigators brochure, CTA will compile a submission within 15 working days and aim to achieve approval in 60 days. This can be reduced to 30 days if no scientific or ethical queries are received.

Research Governance

CTA operates in the Australian State of Victoria and utilises a standard clinical agreement and Institutional Indemnity approved by Medicine Australia (peak organisation for the Australian Pharmaceutical Industry) and the Victorian Managed Insurance Authority (VMIA).These agreements are entered into between CTA and the sponsor on behalf of all participating trial centres.

Clinical Trial Budgets are constructed with the sponsor on behalf of all participating sites. CTA produces line item budget for transparency. Such budgets will describe per visit all labour costs, analytical tests, CTA and member site set up costs and ongoing project and financial management costs for the duration of the trial.

The timeframe for completion of Research Governance is often dependent on the sponsor’s response times as head offices and subsidiaries must liaise and may also include the use of clinical research organisations (CRO’s). CTA aims to commence the Research Governance process in parallel to the Institutional Ethics process. In the event clear costs guidelines are received, CTA aims to provide a sponsor with a budget within 3 calendar weeks.

Back to Top